MindBio Therapeutics Corp.
MindBio Therapeutics Corp.
MindBio is a leading biotech/biopharma company focused on creating novel and emerging treatments for mental health conditions and is conducting world first take-home Microdosing (MB22001) human clinical trials. MB22001 is MindBio’s lead candidate drug, a proprietary titratable form of Lysergic Acid Diethylamide (LSD) designed for take-home microdosing. MindBio is a leader in microdosing of psychedelic medicines and is advancing its drug and technology protocols through clinical trials. MindBio has developed a multi-disciplinary platform for developing treatments and is involved in psychedelic medicine development and digital therapeutics, has completed Phase 1 clinical trials in 80 healthy participants, has a Phase 2a clinical trial just completed microdosing in patients with Major Depressive Disorder and a Phase 2B clinical trial currently underway microdosing in late stage cancer patients experiencing existential distress. The Company has also started dosing in a Phase 2B Depression Trial. MindBio invests in research that forms the basis for developing novel and clinically proven treatments including digital technologies and interventions to treat debilitating health conditions such as depression, anxiety and other related mental health conditions.
MindBio Therapeutics Corp. (MBIO)
MindBio Therapeutics Corp. (MBIO)
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| Desjardins Securities Inc. | 34,000 | 0.005 | 0.01 | 309,000 | Anonymous |
| RBC Capital Markets | 200,000 | 0.005 | 0.01 | 50,000 | National Bank Financial Inc. |
| TD Securities Inc. | 150,000 | 0.005 | 0.01 | 20,000 | CIBC World Markets Inc. |
| TD Securities Inc. | 150,000 | 0.005 | 0.015 | 60,000 | National Bank Financial Inc. |
| National Bank Financial Inc. | 118,000 | 0.005 | 0.015 | 10,000 | CIBC World Markets Inc. |
| TD Securities Inc. | 100,000 | 0.005 | 0.015 | 150,000 | BMO Nesbitt Burns Inc. |
| TD Securities Inc. | 50,000 | 0.005 | 0.015 | 7,000 | National Bank Financial Inc. |
| CIBC World Markets Inc. | 33,000 | 0.005 | 0.02 | 20,000 | National Bank Financial Inc. |
| BMO Nesbitt Burns Inc. | 280,000 | 0.005 | 0.02 | 25,000 | BMO Nesbitt Burns Inc. |
| TD Securities Inc. | 60,000 | 0.005 | 0.02 | 20,000 | National Bank Financial Inc. |
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 27 | 2,501,000 | 0.005 | 0.01 | 379,000 | 3 |
| 0 | 0 | 0.00 | 0.015 | 227,000 | 4 |
| 0 | 0 | 0.00 | 0.02 | 244,000 | 8 |
| 0 | 0 | 0.00 | 0.025 | 79,000 | 4 |
| 0 | 0 | 0.00 | 0.03 | 132,000 | 6 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| Date/Time | Price | Change | Volume | Buyer | Seller | Venue |
|---|---|---|---|---|---|---|
| Apr 4, 18:59 | 0.005 | -0.005 | 20,000 | CIBC World Markets Inc. | CIBC World Markets Inc. | CSE |
| Apr 4, 15:40 | 0.01 | 0.00 | 1,000 | National Bank Financial Inc. | Anonymous | CSE |
| Apr 4, 15:05 | 0.01 | 0.00 | 2,000 | TD Securities Inc. | Anonymous | CSE |
| Apr 4, 13:50 | 0.005 | -0.005 | 2,000 | National Bank Financial Inc. | National Bank Financial Inc. | CSE |
| Apr 4, 13:50 | 0.01 | 0.00 | 25,000 | RBC Capital Markets | Anonymous | CSE |
Company Info
SEDAR Information
Company Info
Capitalization
Company Officers
News Releases
MindBio Acquires Life AI Corp
Bulletins
2023-0505 - New Listing - MindBio Therapeutics Corp. (MBIO)
le 4 mai/May 2023
The common shares of MindBio Therapeutics Corp. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
